by John Conrad | Nov 24, 2020 | 2019 Fed Issue, iBIO News
The Illinois Biotechnology Innovation Organization (iBIO) opposes the Trump Administration’s decision to move forward with the flawed concept of a “Most Favored Nation” policy. This inadequate regulation will dramatically affect the most vulnerable...
by John Conrad | Sep 27, 2019 | 2019 Fed Issue, Policy News
On Sept. 19, House Speaker Nancy Pelosi (D-San Francisco) unveiled legislation in the form of the Lower Drug Costs Now Act (H.R. 3) Illinois is home to over 45,000 researchers, doctors, lawyers and business women and men in the biopharma industry who have an...
by John Conrad | Jul 1, 2019 | 2019 Fed Issue
The HELP Committee advanced the Lower Health Care Costs Act of 2019 (S. 1895). While the bill deals with health care costs more broadly, it also contains provisions on drug pricing (such as the CREATES Act). The Committee adopted an amendment introduced by Senator...
by John Conrad | Jul 1, 2019 | 2019 Fed Issue
The Affordable Prescriptions for Patients Act (S. 1416), introduced by Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), was approved unanimously by the Judiciary Committee last week, as amended. As originally drafted, the bill would have granted the Federal...
by John Conrad | Jun 24, 2019 | 2019 Fed Issue
Summary President Trump’s administration outlined proposed changes to the Medicare Part B program that would dramatically affect most vulnerable seniors and patient communities that don’t yet have a single therapy for their disease. Medicare Part B supports the...
by John Conrad | Jun 24, 2019 | 2019 Fed Issue
Summary This bill repeals the excise tax on the sale of a medical device by the manufacturer, producer, or importer. The medical device excise tax is a 2.3% excise tax on the sale of certain medical technology that was enacted as part of the Affordable Care Act....
